Mathilde Allard

1.1k total citations
21 papers, 705 citations indexed

About

Mathilde Allard is a scholar working on Immunology, Oncology and Epidemiology. According to data from OpenAlex, Mathilde Allard has authored 21 papers receiving a total of 705 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Immunology, 9 papers in Oncology and 3 papers in Epidemiology. Recurrent topics in Mathilde Allard's work include Immune Cell Function and Interaction (12 papers), T-cell and B-cell Immunology (11 papers) and CAR-T cell therapy research (8 papers). Mathilde Allard is often cited by papers focused on Immune Cell Function and Interaction (12 papers), T-cell and B-cell Immunology (11 papers) and CAR-T cell therapy research (8 papers). Mathilde Allard collaborates with scholars based in Switzerland, France and United States. Mathilde Allard's co-authors include Nathalie Rufer, Daniel E. Speiser, Philippe O. Gannon, Michaël Hebeisen, Nadine Gervois, Pierre‐Yves Dietrich, Valérie Dutoit, Paul R. Walker, Romain Oger and Laurène Cagnon and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Oncogene.

In The Last Decade

Mathilde Allard

21 papers receiving 699 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mathilde Allard Switzerland 16 536 322 146 61 58 21 705
Stephanie Dorta‐Estremera United States 13 664 1.2× 350 1.1× 315 2.2× 65 1.1× 57 1.0× 30 875
Chun‐Jen J. Chen New Zealand 11 936 1.7× 283 0.9× 256 1.8× 75 1.2× 32 0.6× 15 1.1k
Andrew Medvec United States 8 455 0.8× 326 1.0× 134 0.9× 87 1.4× 103 1.8× 8 736
Renee Wu United States 9 726 1.4× 383 1.2× 194 1.3× 43 0.7× 32 0.6× 13 930
Maximillian Rosario United States 11 945 1.8× 541 1.7× 150 1.0× 74 1.2× 67 1.2× 19 1.1k
Erika J. Crosby United States 13 314 0.6× 256 0.8× 161 1.1× 53 0.9× 40 0.7× 24 573
Meghali Goswami United States 13 321 0.6× 198 0.6× 249 1.7× 67 1.1× 44 0.8× 33 692
Caroline Boudousquié Switzerland 12 715 1.3× 409 1.3× 361 2.5× 46 0.8× 25 0.4× 17 1.1k
Yoshie Kametani Japan 15 434 0.8× 111 0.3× 212 1.5× 61 1.0× 34 0.6× 61 661
Samuel Alsén Sweden 9 513 1.0× 277 0.9× 191 1.3× 43 0.7× 35 0.6× 15 737

Countries citing papers authored by Mathilde Allard

Since Specialization
Citations

This map shows the geographic impact of Mathilde Allard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mathilde Allard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mathilde Allard more than expected).

Fields of papers citing papers by Mathilde Allard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mathilde Allard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mathilde Allard. The network helps show where Mathilde Allard may publish in the future.

Co-authorship network of co-authors of Mathilde Allard

This figure shows the co-authorship network connecting the top 25 collaborators of Mathilde Allard. A scholar is included among the top collaborators of Mathilde Allard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mathilde Allard. Mathilde Allard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Doix, Bastien, Laura Carretero-Iglesia, Mathilde Allard, et al.. (2023). Overall avidity declines in TCR repertoires during latent CMV but not EBV infection. Frontiers in Immunology. 14. 1 indexed citations
2.
Allard, Mathilde, et al.. (2022). Linking unfolded protein response to ovarian cancer cell fusion. BMC Cancer. 22(1). 622–622. 13 indexed citations
3.
Seguin, Laetitia, Francesca Corlazzoli, Mayra Yebra, et al.. (2021). Macropinocytosis requires Gal-3 in a subset of patient-derived glioblastoma stem cells. Communications Biology. 4(1). 718–718. 13 indexed citations
4.
Allard, Mathilde, Nicolas Chouin, Sébastien Gouard, et al.. (2021). Targeted Alpha Particle Therapy Remodels the Tumor Microenvironment and Improves Efficacy of Immunotherapy. International Journal of Radiation Oncology*Biology*Physics. 112(3). 790–801. 15 indexed citations
5.
Parrot, Tiphaine, Romain Oger, Mathilde Allard, et al.. (2020). Transcriptomic features of tumour-infiltrating CD4lowCD8high double positive αβ T cells in melanoma. Scientific Reports. 10(1). 5900–5900. 20 indexed citations
6.
Marinari, Eliana, Mathilde Allard, Valérie Widmer, et al.. (2020). Inflammation and lymphocyte infiltration are associated with shorter survival in patients with high-grade glioma. OncoImmunology. 9(1). 1779990–1779990. 29 indexed citations
7.
Allard, Mathilde, et al.. (2019). Peptides as cancer vaccines. Current Opinion in Pharmacology. 47. 20–26. 78 indexed citations
8.
Wang, Chensu, Mona O. Mohsen, Nathalie Rufer, et al.. (2019). Murine CD8 T‐cell functional avidity is stable in vivo but not in vitro: Independence from homologous prime/boost time interval and antigen density. European Journal of Immunology. 50(4). 505–514. 5 indexed citations
9.
Jouand, Nicolas, Céline Bressollette‐Bodin, Nathalie Gérard, et al.. (2018). HCMV triggers frequent and persistent UL40-specific unconventional HLA-E-restricted CD8 T-cell responses with potential autologous and allogeneic peptide recognition. PLoS Pathogens. 14(4). e1007041–e1007041. 33 indexed citations
10.
Allard, Mathilde, Laura Carretero-Iglesia, Minh Ngoc Duong, et al.. (2017). TCR-ligand dissociation rate is a robust and stable biomarker of CD8+ T cell potency. JCI Insight. 2(14). 30 indexed citations
11.
Duong, Minh Ngoc, Mathilde Allard, Manfredo Quadroni, et al.. (2017). Fine-Tuning of Optimal TCR Signaling in Tumor-Redirected CD8 T Cells by Distinct TCR Affinity-Mediated Mechanisms. Frontiers in Immunology. 8. 1564–1564. 44 indexed citations
12.
Ioannidou, Kalliopi, Petra Baumgaertner, Philippe O. Gannon, et al.. (2017). Heterogeneity assessment of functional T cell avidity. Scientific Reports. 7(1). 44320–44320. 10 indexed citations
13.
Parrot, Tiphaine, Mathilde Allard, Romain Oger, et al.. (2016). IL‐9 promotes the survival and function of human melanoma‐infiltrating CD4+CD8+ double‐positive T cells. European Journal of Immunology. 46(7). 1770–1782. 27 indexed citations
14.
Marraco, Silvia A. Fuertes, Charlotte Soneson, Laurène Cagnon, et al.. (2015). Long-lasting stem cell–like memory CD8 + T cells with a naïve-like profile upon yellow fever vaccination. Science Translational Medicine. 7(282). 282ra48–282ra48. 149 indexed citations
15.
Hebeisen, Michaël, Mathilde Allard, Philippe O. Gannon, et al.. (2015). Identifying Individual T Cell Receptors of Optimal Avidity for Tumor Antigens. Frontiers in Immunology. 6. 582–582. 58 indexed citations
16.
Allard, Mathilde, Romain Oger, Houssem Benlalam, et al.. (2014). Soluble HLA-I/Peptide Monomers Mediate Antigen-Specific CD8 T Cell Activation through Passive Peptide Exchange with Cell-Bound HLA-I Molecules. The Journal of Immunology. 192(11). 5090–5097. 15 indexed citations
17.
Allard, Mathilde, Pierre Tonnerre, Steven Nédellec, et al.. (2012). HLA-E-Restricted Cross-Recognition of Allogeneic Endothelial Cells by CMV-Associated CD8 T Cells: A Potential Risk Factor following Transplantation. PLoS ONE. 7(11). e50951–e50951. 29 indexed citations
18.
Fregni, Giulia, Aurélie Perier, Gianfranco Pittari, et al.. (2011). Unique Functional Status of Natural Killer Cells in Metastatic Stage IV Melanoma Patients and Its Modulation by Chemotherapy. Clinical Cancer Research. 17(9). 2628–2637. 48 indexed citations
19.
Perier, Aurélie, Giulia Fregni, Sébastian Wittnebel, et al.. (2011). Mutations of the von Hippel–Lindau gene confer increased susceptibility to natural killer cells of clear-cell renal cell carcinoma. Oncogene. 30(23). 2622–2632. 21 indexed citations
20.
Allard, Mathilde, Romain Oger, Virginie Vignard, et al.. (2011). Serum Soluble HLA-E in Melanoma: A New Potential Immune-Related Marker in Cancer. PLoS ONE. 6(6). e21118–e21118. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stephanie Dorta‐Estremera Breakdown of academic impact, for papers by Chun‐Jen J. Chen Breakdown of academic impact, for papers by Andrew Medvec Breakdown of academic impact, for papers by Renee Wu Breakdown of academic impact, for papers by Maximillian Rosario Breakdown of academic impact, for papers by Erika J. Crosby Breakdown of academic impact, for papers by Meghali Goswami Breakdown of academic impact, for papers by Caroline Boudousquié Breakdown of academic impact, for papers by Yoshie Kametani Breakdown of academic impact, for papers by Samuel Alsén
Rankless by CCL
2026